Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Skin Neoplasms 3Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Melanoma 2Carcinoma, Hepatocellular 2Turcot syndrome 1Recurrence 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Mouth Neoplasms 1Malignant Ascites 1Liver Neoplasms 1Head and Neck Neoplasms 1Glioma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Small Cell 1Carcinoma, Endometrioid 1Carcinoma 1

Interventions

spartalizumab 1pembrolizumab 1Platinum 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Non-small Cell Lung Cancer Metastatic × pembrolizumab × Clear all
NCT04793815 2023-06-29

Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)

Centre hospitalier de l'Université de Montréal (CHUM)

Phase NA Completed
15 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡